Literature DB >> 4611292

Synergistic action of amphotericin B and rifampin on Candida albicans.

W H Beggs, G A Sarosi, F A Andrews.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4611292     DOI： 10.1164/arrd.1974.110.5.671

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  14 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

Review 2.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

3.  Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.

Authors:  M A Ghannoum; M S Motawy; M A Abu Hatab; A S Ibrahim; R S Criddle
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

4.  Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

Authors:  S C Harris; J E Wallace; G Foulds; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

5.  Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.

Authors:  M Huppert; D Pappagianis; S H Sun; I Gleason-Jordan; M S Collins; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

Authors:  T Vago; G Baldi; D Colombo; M Barbareschi; G Norbiato; F Dallegri; M Bevilacqua
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination.

Authors:  K K Lee; S L Karr; M M Wong; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

Review 9.  Use of rifampin in nonstaphylococcal, nonmycobacterial disease.

Authors:  A B Morris; R B Brown; M Sands
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

Review 10.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.